Cite
MLA Citation
A Dignass et al.. “P469 The PROPER study: interim analysis of a pan-European real-world study of SB5 adalimumab biosimilar after transition from reference adalimumab in patients with Crohn's disease.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S459–S460. http://access.bl.uk/ark:/81055/vdc_100130765543.0x000020